Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 13, 2019 6:07pm
51 Views
Post# 29917386

RE:RE:RE:RE:RE:50 cent PP VS 35 cents

RE:RE:RE:RE:RE:50 cent PP VS 35 cents
skier59 wrote: I would wait 6 Months to start the others. All we need is HC results at 6 months. Nothing else matters until that point. This is what we as SHAREHOLDERS were to believe. WEE ALLL invested to see this NMIBC achieve success.......NOTHING ELSE MATTERS.

Put the brakes on for 6 months and watch what HC success in that 1 indication can do to our SP. YOU guys want to spread us thin at a very important time in this whole 5 year trip many of us have been on. The SP has not moved forward, and it needs to to create Shareholder value, which many deserve to see in their portfolios. Fine and dandy to say our science continues to advance, love it. RIGHT NOW it is time to think SMART and we Shareholders will appreciate it.

6 months CR 90-100% HC Phase2 study should be worth well over $500 MILLION....and in all honesty I think closer to $2 BILLION.




Claridge wrote: Skier59 ... Do only Ph. 2b and do nothing else to also advance other indications like GBM and NSCLC??? 

Have you ever estimated what just 1 month of revenues earlier than expected from only these 2 mega indications would bring in the coffers and in term of market valuation?  Just one hint;  much more than the net dilution that you're currently talking about.

And only focusing on Ph. 2b would not allow you to enroll US sites much earlier.

TLT in the meantime, can produce interim data from its NMIBC Ph. 2b with for example interim data on its primary site (UHN) or all its canadian sites, while still advancing their other indications (GBM, NMIBC, etc ...).  All biotechs do this type of parallelism pattern, instead of going one indication at a time, so at one point in time, they have many indications spanned across different stages of clinical phases.  

So not much time is wasted here in terms of advancing on many fronts, as fast as possible, with the money that will be provided, with a clear focus on the NMIBC Ph. 2b, as it's the closest one to commercialization.

It always come back about managing the burn rate. 





To "Think Smart.." , you just can't expect the pimp (prostitute) management like Stockholm syndrome patient Kristina to have normal mind not to mention "think smart....
Bullboard Posts